500 Companies Show Interest In Hyderabad Pharma City

Hyderabad : The Hyderabad Pharma City (HPC), the flagship pharma park being developed by the Telangana Government, has been drawing enthusiastic response from the industry.

“So far, about 500 pharma and life sciences companies have expressed interest in setting up facilities in the upcoming city,’‘ a senior official of the Telangana State Industrial Infrastructure Corporation ((TSIIC) told businessline on Thursday.

HPC is proposed to be developed as the world’s largest integrated cluster in Hyderabad for pharmaceutical industries, thrusting on R&D and manufacturing and is expected to attract investments to the tune of $10 billion.

All domestic and global pharma majors are ready to set up their units in the pharma city coming up at about 25 km from Shamshabad airport, the official said, adding: “The entire land acquisition for the project has been completed.’‘

While the Government was keen on launching the project formally a few months ago, a small part of the land acquired got into legal issues and the matter is pending before the High Court now. “The matter is subjudice now. We can’t say more. However, we will proceed with allotment of land in HPC for the manufacturers immediately after the matter is resolved,’‘ he said.

According to the Government data, the life sciences sector in Telangana attracted ₹6,400 crore investment from 215 companies in 2021-22 which was 200 per cent more than the investment attracted by the industry at ₹2,766 crore from about 150 companies in FY21. The data for FY23 is yet to be released.

Related Posts

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

Meerut: A four-year-old boy’s condition allegedly worsened after he was administered an anti-rabies injection at Sambhal district hospital following a snakebite. A pharmacist at the hospital has been removed from…

Lupin gets tentative US FDA nod for apixaban oral suspension for patients who cannot swallow tablets

Once final approval comes through, the liquid anticoagulant will be made at Lupin’s plant in Somerset, New Jersey, the company said. Mumbai: Lupin has received tentative approval from the US…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore

Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore